These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 19628751)

  • 1. Further studies on the role of metabolites in (+/-)-3,4-methylenedioxymethamphetamine-induced serotonergic neurotoxicity.
    Mueller M; Yuan J; Felim A; Neudörffer A; Peters FT; Maurer HH; McCann UD; Largeron M; Ricaurte GA
    Drug Metab Dispos; 2009 Oct; 37(10):2079-86. PubMed ID: 19628751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of 3,4-methylenedioxymethamphetamine (MDMA) and its main metabolites on cardiovascular function in conscious rats.
    Schindler CW; Thorndike EB; Blough BE; Tella SR; Goldberg SR; Baumann MH
    Br J Pharmacol; 2014 Jan; 171(1):83-91. PubMed ID: 24328722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of 3,4-methylenedioxymethamphetamine metabolism leads to marked decrease in 3,4-dihydroxymethamphetamine formation but no change in serotonin neurotoxicity: implications for mechanisms of neurotoxicity.
    Mueller M; Yuan J; Maldonado Adrian C; McCann UD; Ricaurte GA
    Synapse; 2011 Oct; 65(10):983-90. PubMed ID: 21360595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glutathione and N-acetylcysteine conjugates of alpha-methyldopamine produce serotonergic neurotoxicity: possible role in methylenedioxyamphetamine-mediated neurotoxicity.
    Bai F; Lau SS; Monks TJ
    Chem Res Toxicol; 1999 Dec; 12(12):1150-7. PubMed ID: 10604863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonlinear pharmacokinetics of (+/-)3,4-methylenedioxymethamphetamine (MDMA) and its pharmacodynamic consequences in the rat.
    Concheiro M; Baumann MH; Scheidweiler KB; Rothman RB; Marrone GF; Huestis MA
    Drug Metab Dispos; 2014 Jan; 42(1):119-25. PubMed ID: 24141857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonlinear pharmacokinetics of (+/-)3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") and its major metabolites in squirrel monkeys at plasma concentrations of MDMA that develop after typical psychoactive doses.
    Mueller M; Peters FT; Maurer HH; McCann UD; Ricaurte GA
    J Pharmacol Exp Ther; 2008 Oct; 327(1):38-44. PubMed ID: 18591215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydrolysis of 3,4-methylenedioxymethamphetamine (MDMA) metabolite conjugates in human, squirrel monkey, and rat plasma.
    Mueller M; Kolbrich-Spargo EA; Peters FT; Huestis MA; Ricaurte GA; Maurer HH
    Anal Bioanal Chem; 2009 Mar; 393(6-7):1607-17. PubMed ID: 19183967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3,4-Dihydroxymethamphetamine (HHMA). A major in vivo 3,4-methylenedioxymethamphetamine (MDMA) metabolite in humans.
    Segura M; Ortuño J; Farré M; McLure JA; Pujadas M; Pizarro N; Llebaria A; Joglar J; Roset PN; Segura J; de La Torre R
    Chem Res Toxicol; 2001 Sep; 14(9):1203-8. PubMed ID: 11559034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonergic neurotoxic thioether metabolites of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy"): synthesis, isolation, and characterization of diastereoisomers.
    Pizarro N; de la Torre R; Joglar J; Okumura N; Perfetti X; Lau SS; Monks TJ
    Chem Res Toxicol; 2008 Dec; 21(12):2272-9. PubMed ID: 19548351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validated liquid chromatographic-electrospray ionization mass spectrometric assay for simultaneous determination of 3,4-methylenedioxymethamphetamine and its metabolites 3,4-methylenedioxyamphetamine, 3,4-dihydroxymethamphetamine, and 4-hydroxy-3-methoxymethamphetamine in squirrel monkey plasma.
    Mueller M; Peters FT; Ricaurte GA; Maurer HH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Aug; 855(2):262-70. PubMed ID: 17646137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereochemical analysis of 3,4-methylenedioxymethamphetamine and its main metabolites in human samples including the catechol-type metabolite (3,4-dihydroxymethamphetamine).
    Pizarro N; Farré M; Pujadas M; Peiró AM; Roset PN; Joglar J; de la Torre R
    Drug Metab Dispos; 2004 Sep; 32(9):1001-7. PubMed ID: 15319342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and in vitro cytotoxicity profile of the R-enantiomer of 3,4-dihydroxymethamphetamine (R-(-)-HHMA): comparison with related catecholamines.
    Felim A; Herrera G; Neudörffer A; Blanco M; O'Connor JE; Largeron M
    Chem Res Toxicol; 2010 Jan; 23(1):211-9. PubMed ID: 20017534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative study on the acute and long-term effects of MDMA and 3,4-dihydroxymethamphetamine (HHMA) on brain monoamine levels after i.p. or striatal administration in mice.
    Escobedo I; O'Shea E; Orio L; Sanchez V; Segura M; de la Torre R; Farre M; Green AR; Colado MI
    Br J Pharmacol; 2005 Jan; 144(2):231-41. PubMed ID: 15665862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of MDMA and its three metabolites in the rat perfused liver.
    Jamali B; Ardakani YH; Foroumadi A; Kobarfard F; Rouini MR
    J Anal Toxicol; 2013; 37(6):357-61. PubMed ID: 23729636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glial cell response to 3,4-(+/-)-methylenedioxymethamphetamine and its metabolites.
    Herndon JM; Cholanians AB; Lau SS; Monks TJ
    Toxicol Sci; 2014 Mar; 138(1):130-8. PubMed ID: 24299738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and capillary electrophoretic analysis of enantiomerically enriched reference standards of MDMA and its main metabolites.
    Pizarro N; de la Torre R; Farré M; Segura J; Llebaria A; Joglar J
    Bioorg Med Chem; 2002 Apr; 10(4):1085-92. PubMed ID: 11836119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of glutathione synthesis and conjugation by 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-dihydroxymethamphetamine (HHMA) in human and rat liver cells, including the protective role of some antioxidants.
    Antolino-Lobo I; Meulenbelt J; Molendijk J; Nijmeijer SM; Scherpenisse P; van den Berg M; van Duursen MB
    Toxicology; 2011 Nov; 289(2-3):175-84. PubMed ID: 21871945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies of (±)-3,4-methylenedioxymethamphetamine (MDMA) metabolism and disposition in rats and mice: relationship to neuroprotection and neurotoxicity profile.
    Mueller M; Maldonado-Adrian C; Yuan J; McCann UD; Ricaurte GA
    J Pharmacol Exp Ther; 2013 Feb; 344(2):479-88. PubMed ID: 23209329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of MDMA (ecstasy) and two of its metabolites on rat embryos in vitro.
    Barenys M; Flick B; Boix N; Almeida B; Joglar J; Klug S; Llobet JM
    Reprod Toxicol; 2012 Aug; 34(1):57-65. PubMed ID: 22391229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, in vitro formation, and behavioural effects of glutathione regioisomers of alpha-methyldopamine with relevance to MDA and MDMA (ecstasy).
    Easton N; Fry J; O'Shea E; Watkins A; Kingston S; Marsden CA
    Brain Res; 2003 Oct; 987(2):144-54. PubMed ID: 14499958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.